Physician Track

Dr. Mark Goetting is an Associate Professor of Pediatrics and Medicine at Western Michigan University Homer Stryker School of Medicine. He is the president of the Michigan Academy of Sleep Medicine and the president of the Sleep Medicine section of the American College of Lifestyle Medicine. He is board-certified in sleep medicine, behavioral sleep medicine, obesity medicine, lifestyle medicine, pediatrics, and neurology. He recently became certified in psychedelic-assisted therapy and research.

Presentation Description
We are in our fifth decade of CPAP use. The technical evolution led to more options, comfort, and feedback for its treatment of obstructive sleep apnea (OSA). The irony is that despite all this progress, many well-funded clinical trials show no reduction in cardiovascular disease and mortality. This presentation reviews theoretical benefits and harms of untreated OSA, the potential benefits and harms of CPAP, where KPAP may fit in, and the incorporation of lifestyle therapies and weight reduction as sleep center-directed interventions.

Learning Objectives

Identify and explain an example of diet-inducing atherosclerosis in the presence of intermittent hypoxemia
List two endogenous circulating substances that appear adversely affected by higher levels of CPAP
Describe the results of the first NASA study on OSA